CHADDS FORD, Pa., Aug. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc.
(Nasdaq: ENDP), a specialty pharmaceutical company with market leadership in pain management, today announced the appointment of George F. Horner III
to its board of directors.Horner, the former chief executive officer and director of Vicuron Pharmaceuticals Inc., replaces Joseph T. O'Donnell, Jr., who has resigned.
..."We are delighted to welcome to the Endo board an executive with the kind of broad-based pharmaceutical industry experience that George Horner brings, and we look forward to his counsel as Endo continues its growth as a leading specialty pharmaceutical company," said Peter A. Lankau, president and chief executive officer.
...Horner was the president and chief executive officer and a member of the board of directors of Vicuron Pharmaceuticals Inc. from 1996 until its acquisition by Pfizer Inc. in September 2005.Prior to joining Vicuron, Horner was corporate vice president of Ligand Pharmaceuticals from 1993 to 1995.He also served in a number of executive positions during his 17 years at Abbott Laboratories from 1976 to 1993, including president, Canada; regional director, Latin America; general manager, Mexico; general manager, Southern Africa Region; and regional manager, Southeast Asia.Horner began his career in the pharmaceutical industry at E.R. Squibb, Inc., where he served in a number of sales and product management positions.